Literature DB >> 20517687

Hereditary diffuse gastric cancer.

Kasmintan Schrader1, David Huntsman.   

Abstract

Gastric cancer is one of the world's leading causes of cancer mortality. A small percentage of cases can be attributed to heritable mutations in highly penetrant cancer susceptibility genes. In this chapter we will focus on the genetic cause of hereditary diffuse gastric cancer (HDGC). Until 10 years ago, individuals from these families lived with the uncertainty of developing lethal gastric cancer. Today, HDGC families can be identified, tested for causative mutations in CDH1, and for those families where a pathogenic mutation can be identified, prophylactic total gastrectomy can be implemented in asymptomatic mutation carriers who elect to virtually eliminate their risk of developing this lethal disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20517687     DOI: 10.1007/978-1-4419-6033-7_3

Source DB:  PubMed          Journal:  Cancer Treat Res        ISSN: 0927-3042


  3 in total

1.  The founder Ashkenazi Jewish mutations in the MSH2 and MSH6 genes in Israeli patients with gastric and pancreatic cancer.

Authors:  Yael Laitman; Liron Herskovitz; Talia Golan; Bella Kaufman; Shani Shimon Paluch; Eitan Friedman
Journal:  Fam Cancer       Date:  2012-06       Impact factor: 2.375

Review 2.  Diagnostic, Predictive, Prognostic, and Therapeutic Molecular Biomarkers in Third Millennium: A Breakthrough in Gastric Cancer.

Authors:  Nicola Carlomagno; Paola Incollingo; Vincenzo Tammaro; Gaia Peluso; Niccolò Rupealta; Gaetano Chiacchio; Maria Laura Sandoval Sotelo; Gianluca Minieri; Antonio Pisani; Eleonora Riccio; Massimo Sabbatini; Umberto Marcello Bracale; Armando Calogero; Concetta Anna Dodaro; Michele Santangelo
Journal:  Biomed Res Int       Date:  2017-09-28       Impact factor: 3.411

Review 3.  Gastric biomarkers: a global review.

Authors:  Nick Baniak; Jenna-Lynn Senger; Shahid Ahmed; S C Kanthan; Rani Kanthan
Journal:  World J Surg Oncol       Date:  2016-08-11       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.